Alice Springs Hospital Readmission Prevention Project
Funder
National Health and Medical Research Council
Funding Amount
$124,608.00
Summary
The Alice Springs Hospital Readmission Project is a collaboration between Alice Springs Hospital and the Baker IDI in Central Australia. Recurrent readmissions can lead to hospital overcrowding and remove a person from their community. The project will investigate whether a tailored discharge planning and case management approach for adult patients with complex chronic disease is beneficial in reducing recurrent readmissions to hospital and facilitating engagement with primary care services.
Subjective wellbeing and depression in Australia: A longitudinal study involving people in remote locations. This project is an extension of the Australian Unity Wellbeing surveys currently conducted as in a partnership between the industry partner and Deakin University. The project will involve the participants of current cross-sectional surveys into a longitudinal study. There are three aims: To investigate the ability of decreased levels of subjective wellbeing to signal depression; To tr ....Subjective wellbeing and depression in Australia: A longitudinal study involving people in remote locations. This project is an extension of the Australian Unity Wellbeing surveys currently conducted as in a partnership between the industry partner and Deakin University. The project will involve the participants of current cross-sectional surveys into a longitudinal study. There are three aims: To investigate the ability of decreased levels of subjective wellbeing to signal depression; To track the normal course of subjective wellbeing recovery following a life event that has caused it to decrease; To monitor the subjective wellbeing of rural-remote Australians. These outcomes will provide further understanding of depression and the wellbeing of Australians living in remote setting.Read moreRead less
INVESTIGATIONS INTO THE BIOLOGICAL FUNCTIONING AND PROGNOSTIC VALUE OF NOVEL METASTATIC MARKERS FOR BREAST CANCER
Funder
National Health and Medical Research Council
Funding Amount
$423,564.00
Summary
Breast cancer is the most malignant tumour of women and, despite great advances in detection and treatment, some 30% of women who present with primary breast cancer eventually relapse or die of their disease. Genetic studies have resulted in the rapid identification of the one-third of women at high risk of developing breast cancer because of a family history of the disease: it is hoped that these women will eventually benefit from advances in gene therapy now being developed. For the majority o ....Breast cancer is the most malignant tumour of women and, despite great advances in detection and treatment, some 30% of women who present with primary breast cancer eventually relapse or die of their disease. Genetic studies have resulted in the rapid identification of the one-third of women at high risk of developing breast cancer because of a family history of the disease: it is hoped that these women will eventually benefit from advances in gene therapy now being developed. For the majority of women developing breast cancer, however, the outcome, or prognosis, remains uncertain. The most important indicators of outcome are obtained by study of the excised cancer tissue, and these relate to the speed of growth of the cancer cells and their ability to migrate, or metastasise, to other sites in the body. Studies of cancer tissue using molecular cell biological methods has enabled the identification of several markers that are proving useful as indicators of outcome, and further understanding of the biological functioning of these markers will enable these molecules to be targetted in new treatments aimed at preventing the spread of the cancer. The present study will examine the appearance of new markers for cell migration among breast cancers and measure their value as indicators of outcome. One molecule in particular may be useful as a therapeutic target since it is used by migrating cells during development but is not expressed by normal (non-cancer) adult tissue cells. Towards this, the project will seek to understand how this molecule functions in cell migration.Read moreRead less
The role of the other in self-regulation: Who, when, where, how, and why. We assume that some individuals, because of the role they have (e.g., parents), are significant others. Moreover, we assume that significant others influence our emotions, motivation, and behaviour. These assumptions have not been systematically tested using a self-regulatory framework. Also no coherent model, detailing how and why individuals come to be significant and the mechanisms by which they have an influence, ha ....The role of the other in self-regulation: Who, when, where, how, and why. We assume that some individuals, because of the role they have (e.g., parents), are significant others. Moreover, we assume that significant others influence our emotions, motivation, and behaviour. These assumptions have not been systematically tested using a self-regulatory framework. Also no coherent model, detailing how and why individuals come to be significant and the mechanisms by which they have an influence, has been proposed. We present a theoretical model to be tested in a sequence of 10 studies. The results will provide understanding of the role of significant others that will have applications in clinical settings and in organisational contexts.Read moreRead less
Australian Laureate Fellowships - Grant ID: FL120100108
Funder
Australian Research Council
Funding Amount
$2,849,770.00
Summary
Surrogate ecology: when and where can it work to improve environmental management? New empirical analyses and new ecological theory will be used to discover where, when and how to best apply surrogates. New capacity will be built in surrogate ecology and the results used to significantly enhance the effective management and monitoring of environments and biodiversity both in Australia and worldwide.